Analysis revealed a mutation in KIT at codon G961S, PIK3CA and MYC gene amplifications that were not noted on prior testing and confirmed FGFR1 and EGFR amplifications which were previously identified in the progressed rectal tumor tissue. This evidence concerns the gene EGFR and rectal neoplasm.